New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes

SARASOTA, FL, June 29, 2006 – A water-soluble, cinnamon extract has been shown to reduce fasting blood sugar levels in patients with type 2 diabetes, according to a new study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation. This was the first study evaluating the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. The results further add to a growing body of clinical evidence demonstrating supplementation with a water-soluble cinnamon extract may play an important role in managing blood sugar levels and improving insulin function.

The placebo-controlled, double-blind study was designed to determine the effect of a water-soluble cinnamon extract on glycemic control and cardiovascular risk factors in patients with type 2 diabetes. A total of 79 patients with type 2 diabetes not on insulin therapy but treated with oral medication or diet therapy were randomly assigned to take either a cinnamon extract or placebo capsule three times daily for four months. The cinnamon capsule contained 112 mg of water-soluble extract, an equivalent of one gram of cinnamon powder. The cinnamon extract group experienced a significant reduction in fasting plasma glucose levels (10.3%) versus the placebo group (3.4%). Changes in HbA1c and lipid profiles were not statistically significant.

In the U.S., Cinnulin PF is the only water-soluble cinnamon extract ingredient standardized for the recognized active component in cinnamon, double-linked Type-A Polymers. Despite USDA studies showing the health benefits of cinnamon, researchers note that when consumed consistently or in high doses, whole cinnamon and fat-soluble extracts may be toxic. Cinnulin PF retains the active components without the potentially harmful compounds, making it completely safe for everyday use.

"This study, together with a recent clinical trial utilizing Cinnulin PF, provides compelling evidence for the beneficial effects of a water-soluble cinnamon extract on blood sugar levels," stated Tim Romero, executive vice president, Integrity Nutraceuticals International, marketer of Cinnulin PF. "We are excited to see in the coming months results of studies underway that further substantiate the efficacy and safety of Cinnulin PF."

Integrity Nutraceuticals International, founded in 1999, is a global raw material supplier of bulk nutraceuticals. They import only the finest materials from China and India and specialize in custom formulations. Integrity’s focus is to introduce innovative ingredients into the market based on science and research. Their inventory consists of a wide variety of products including: amino acids, creatine, sports enhancing supplements, joint and heath care items, specialty items and herbs. Integrity’s products are verified analytically in their state-of-the-art in-house laboratory equipped with HPLC, FT-NIR, GC and microbial testing.

For more information contact Kathy Bender at 941-342-0007.

# # #

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish